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Abstract
Background: Japanese encephalitis virus (JEV) NS5 is a viral nonstructural protein that carries
both methyltransferase and RNA-dependent RNA polymerase (RdRp) domains. It is a key
component of the viral RNA replicase complex that presumably includes other viral nonstructural
and cellular proteins. The biochemical properties of JEV NS5 have not been characterized due to
the lack of a robust in vitro RdRp assay system, and the molecular mechanisms for the initiation of
RNA synthesis by JEV NS5 remain to be elucidated.
Results: To characterize the biochemical properties of JEV RdRp, we expressed in Escherichia coli
and purified an enzymatically active full-length recombinant JEV NS5 protein with a hexahistidine
tag at the N-terminus. The purified NS5 protein, but not the mutant NS5 protein with an Ala
substitution at the first Asp of the RdRp-conserved GDD motif, exhibited template- and primer-
dependent RNA synthesis activity using a poly(A) RNA template. The NS5 protein was able to use
both plus- and minus-strand 3'-untranslated regions of the JEV genome as templates in the absence
of a primer, with the latter RNA being a better template. Analysis of the RNA synthesis initiation
site using the 3'-end 83 nucleotides of the JEV genome as a minimal RNA template revealed that
the NS5 protein specifically initiates RNA synthesis from an internal site, U81, at the two
nucleotides upstream of the 3'-end of the template.
Conclusion: As a first step toward the understanding of the molecular mechanisms for JEV RNA
replication and ultimately for the in vitro reconstitution of viral RNA replicase complex, we for the
first time established an in vitro JEV RdRp assay system with a functional full-length recombinant JEV
NS5 protein and characterized the mechanisms of RNA synthesis from nonviral and viral RNA
templates. The full-length recombinant JEV NS5 will be useful for the elucidation of the structure-
function relationship of this enzyme and for the development of anti-JEV agents.
Background
Japanese encephalitis virus (JEV) is the most common
cause of epidemic viral encephalitis worldwide, with
approximately 50,000 cases and 15,000 deaths annually
throughout a wide geographical range [1]. Since the pro-
totype Nakayama strain of JEV was first isolated in 1935,
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epidemics and sporadic cases of Japanese encephalitis
have occurred in temperate and tropical zones of Asia as
well as in non-Asian regions, including Cambodia, China,
Indonesia, India, Japan, Malaysia, Myanmar, Nepar, Sri
Lanka, Thailand, Vietnam, the south eastern Russian fed-
eration, and Australia [2,3].
JEV is a member of Flaviviridae family, which consists of
the genera Flavivirus  (JEV, dengue virus [DEN], yellow
fever virus [YF], West Nile virus [WNV], Kunjin virus
[KUN], Murray Valley encephalitis virus), Pestivirus
(bovine viral diarrhea virus [BVDV], Classical swine fever
virus [CSFV]), and Hepacivirus (hepatitis C virus, [HCV]).
JEV is an enveloped, positive-stranded RNA virus whose
genome consists of a single-stranded RNA molecule of
approximately 11 kb. The RNA genome of JEV consists of
98-nucleotide (nt) long 5' untranslated region (UTR) with
the type-1 cap structure at its 5' terminus, a single open
reading frame (ORF), and a 585-nt long 3'-UTR with no
poly(A) tail at its 3' terminus [4]. The single large ORF
encodes a polyprotein of ~3,400 amino acids that is sub-
sequently processed by both host and viral proteases into
three structural proteins and seven nonstructural proteins
[4]. The structural proteins (capsid, membrane, and enve-
lope proteins) are contained in the N-terminal third of the
polyprotein, while the nonstructural proteins (NS1,
NS2A, NS2B, NS3, NS4A, NS4B and NS5) are located in
the C-terminal two-thirds of the polyprotein. NS5 is the
largest nonstructural protein of JEV. Analysis of the amino
acid sequence of NS5 led to the prediction that it carries
both methyltransferase and RNA-dependent RNA
polymerase (RdRp) activities. The 5' RNA methyltrans-
ferase activity should be located on the N-terminal por-
tion because of the presence of conserved motifs found in
other viral methyltransferases [5-7]. The C-terminal
region of NS5, which contains the conserved RdRp motifs
[8,9] and the Gly-Asp-Asp (GDD) motif found in the
active site of many viral RdRps [10], is likely responsible
for the RNA polymerase activity.
RNA synthesis by various RNA virus RdRps has been
shown to occur by either a de novo initiation mechanism
in which first nucleotide serves as a primer to provide the
3'-hydroxyl group, or via a primer-(an oligonucleotide, a
protein linked to nucleotides, or intramolecular self prim-
ing) dependent mechanism [11-16]. De novo initiation
results in the synthesis of various RdRp products includ-
ing a template-size product initiated from the most 3'-end
or an RNA molecule smaller than the template (via inter-
nal initiation) [11,15,17]. Although de novo initiation has
been demonstrated for a number of Flaviviridae RdRps,
including those from WNV, DEN, KUN, BVDV, CSFV, and
HCV [15,17-22], the biochemical properties JEV RdRp
and its RNA synthesis initiation mechanism have not
been yet analyzed in detail due to the lack of an in vitro
RdRp assay system. In this work, we expressed and puri-
fied JEV NS5 protein from Escherichia coli and character-
ized its biochemical properties and in vitro RNA synthesis
initiation mechanism.
Results
Expression and purification of recombinant JEV NS5 
protein
To investigate the biochemical properties of JEV RdRp,
recombinant JEV NS5 protein with a hexahistidine tag at
the N-terminus was expressed in E. coli. The E. coli cells
transformed with an expression vector containing JEV
NS5-coding gene were induced with IPTG at low temper-
ature (18°C) to obtain soluble NS5 protein. Western blot
analysis of the soluble fraction and total lysates with an
anti-His antibody detected ~105-kDa intact JEV NS5 pro-
teins along with ~35-kDa cleaved form of the NS5 (data
not shown). These two proteins were co-purified by nickel
affinity chromatography (Fig. 1A). The proteins were
excised from the gel and in-gel digested with trypsin. The
resulting peptide mixtures were analyzed by MALDI-TOF
mass spectrometry. Both of these proteins were identified
as JEV NS5 protein (data not shown). The 35-kDa C-ter-
minally truncated NS5 proteins were successfully
removed by subsequent gel filtration chromatography
(GFC) (Fig. 1B, lanes 2–4). The GFC fractions containing
the intact form of NS5 were further purified by SP-Sepha-
rose cation exchange chromatography (Fig. 1C). The JEV
NS5 mutant protein NS5D668A was also similarly purified.
The eluate from the SP-Sepharose column contained near
homogenous NS5 proteins, as shown by silver staining
(Fig. 1D) and Western blot analysis (Fig. 1E).
Analysis of the RdRp activity of JEV NS5
To test the RdRp activity of the purified recombinant JEV
NS5 protein, we first performed an RNA polymerase assay
with poly(A) RNA template in the absence and presence
of primer oligo(U)20. The RdRp activity assay conditions
used initially were similar to those for HCV NS5B RdRp
[12], except that 2.5 mM of both Mn2+ and Mg2+ were
added. The RNA polymerase activity of JEV NS5 was only
observed in the presence of primer (Fig. 2A). The GDD
motif conserved in most RdRps of plus-strand RNA
viruses is important for metal binding and is considered
to be the catalytic site of the enzyme [8]. Mutation of the
first Asp in the GDD motif to Ala in NS5D668A resulted in
loss of the RdRp activity (Fig. 2B). These results demon-
strated that the recombinant JEV NS5 RdRp alone is capa-
ble of synthesizing RNA in vitro without the help of other
viral and/or cellular protein(s).
Having identified the RNA polymerase activity of the puri-
fied NS5 protein, we optimized the RdRp assay conditions
by using the poly(A) RNA/oligo(U)20 as a template. The
optimal temperature for maximal activity was determinedBMC Molecular Biology 2007, 8:59 http://www.biomedcentral.com/1471-2199/8/59
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to be 30°C (Fig. 3A). The RdRp activity of JEV NS5 was
found to be optimal at pH of 8.0; rapid decrease of activity
was observed above pH 8 (Fig. 3B). Potassium (K+) ion
exhibited a stimulatory effect at 25 mM, while the stimu-
latory effect decreased when the concentration of K+ was
higher than 25 mM (Fig. 3C). All known DNA and RNA
polymerases require a divalent cation cofactor for optimal
activity [8]. Divalent metal ions are also essential cofactors
for viral RdRps [16]. The enzymatic activity of JEV NS5
was dependent on Mn2+ with the optimal concentration
being 2.5 mM (Fig. 3D). The JEV NS5 exhibited a strong
preference for Mn2+ over Mg2+ for RNA synthesis using the
poly(A)/U20 substrate (Fig. 4A). No detectable level of
RdRp activity was observed in the presence of the same
range of Mg2+ concentration as that used for Mn2+ (0.5 to
10 mM). Similarly, complete dependence on Mn2+ was
observed with a JEV genome-derived RNA template, the
83-nt RNA from the 3'-end of JEV genome (Fig. 4B).
De novo initiation of RNA synthesis from the plus- and 
minus-strand 3'-UTR of JEV genome
Cis-acting RNA elements required for viral RNA replica-
tion by various viral RdRps are known to reside at the 3'-
end of both plus- and minus-strand viral genomes,
thereby allowing initiation of RNA synthesis of both
polarities. To investigate the RNA synthesis initiation
Purification of recombinant JEV NS5 protein Figure 1
Purification of recombinant JEV NS5 protein. JEV NS5 protein was expressed in E. coli and purified by Ni-NTA chroma-
tography, gel filtration chromatography, and ion-exchange chromatography using an SP-Sepharose column. (A) Imidazole elu-
tion profile of JEV NS5 from Ni-NTA resin. (B) Gel filtration chromatography elution profile of JEV NS5. (C) NaCl-elution 
profile of JEV NS5 from an SP-Sepharose column. (A-C) Fractions from each purification step were resolved by SDS-12% 
PAGE and stained with Coomassie brilliant blue. (D) JEV NS5 and its mutant NS5D668A from a peak fraction eluted from an SP-
Sepharose column were resolved by SDS-12% PAGE and visualized by silver staining. (E) Western blot analysis of the purified 
JEV NS5 and NS5D668A using an anti-His6 antibody. The sizes of protein markers are indicated in kilodaltons. Closed and open 
arrowheads indicate the full-length JEV NS5, and its major cleaved form identified by MALDI-TOF analysis, respectively.BMC Molecular Biology 2007, 8:59 http://www.biomedcentral.com/1471-2199/8/59
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mechanism with the purified recombinant JEV NS5, we
performed RdRp assays with JEV genome-derived RNA
templates, 3'(+)UTR and 3'(-)UTR RNA, that represent the
3'-end of JEV plus- and minus-strand RNA, respectively.
The RNA templates were synthesized by in vitro transcrip-
tion using T7 RNA polymerase and PCR-amplified DNA
templates under the control of T7 RNA polymerase pro-
moter. The recombinant JEV NS5 was able to use both JEV
3'(+)UTR and 3'(-)UTR RNA as templates (Figs. 5A–C).
RNA synthesis from these templates did not require an
exogenous primer, indicating that JEV NS5 can start RNA
synthesis de novo using a nucleotide as a primer. The major
RNA product synthesized from the 3' (+)UTR co-migrated
with the template (Fig. 5A, lane 2). In contrast, the major
RNA products synthesized from the 3'(-)UTR RNA tem-
plate migrated slightly slower than the template RNA (Fig.
5B, lane 2). Moreover, through comparison of RNA prod-
uct amounts synthesized from the 3'(+)UTR and 3'(-)UTR
RNA template (Fig. 5C), we found that JEV NS5 appar-
ently recognized a cis-acting element in the 3'(-)UTR more
efficiently than the one in the 3'(+)UTR for the synthesis
of plus-strand JEV RNA. These results indicated that JEV
RdRp assay using a poly(A) template and oligo(U)20 primer Figure 2
RdRp assay using a poly(A) template and oligo(U)20 
primer. (A) Primer-dependent RNA synthesis. RdRp assays 
were performed with the purified JEV NS5 using a poly(A) 
RNA template in the presence (+) or absence (-) of the 
primer oligo(U)20. (B) RdRp assays were performed with the 
purified wild-type NS5 (GDD) and its mutant NS5D668A 
(GAD) in the presence (+) or absence (-) of a poly(A) RNA 
template. Relative RdRp activities (%), which were obtained 
by comparing the 32P-UMP incorporation measured by liquid 
scintillation counting with that obtained for the reaction with 
the template and primer, 3.0 × 105 cpm, are presented.
Optimization of JEV RdRp assay conditions Figure 3
Optimization of JEV RdRp assay conditions. Effect of temperature (A), pH (B), K+ ion (C), and Mn2+ ion (D) on JEV RdRp 
activity. RdRp assays were performed with the poly(A)/(U)20 template under the indicated conditions. The RdRp activity was 
measured as in Figure 2 and is presented as the percentage of that observed under each optimal condition. Shown is the mean 
and standard error from three independent experiments.
Dependence of JEV RdRp activity on Mn2+ion Figure 4
Dependence of JEV RdRp activity on Mn2+ion. (A) 
RdRp assays were performed with the poly(A)/(U)20 template 
(A) in the absence (lane 1) or in the presence of increasing 
concentrations of MgCl2 or MnCl2 (lanes 2–6 and 7–11; 0.5, 
1.0, 2.5, 5.0, and 10 mM of MgCl2 and MnCl2, respectively). 
(B) RdRp assays were performed with the 83-nt RNA repre-
senting the 3' end of the plus-strand JEV genome, in the 
absence of metal ions (lane 1) or in the presence of 2.5 mM 
of the divalent metal ion indicated above the autoradiogram 
(lanes 2 and 3). RdRp products were denatured and resolved 
on a medium size (20 × 20 cm) denaturing 5% polyacrylamide 
gel, and subjected to autoradiography.BMC Molecular Biology 2007, 8:59 http://www.biomedcentral.com/1471-2199/8/59
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NS5 can synthesize RNA de novo using JEV genome-
derived RNA templates. The lack of labeled products with-
out an RNA template (Figs. 5A, B, and 5D, lane 3) indi-
cated that the JEV NS5 preparation was not contaminated
with any RNAs that could serve as a template. In addition,
no RNA products were synthesized by the JEV NS5 mutant
NS5D668A, indicating that the NS5 protein was not associ-
ated with enzymes that can label exogenous RNA tem-
plates (Figs. 5A, B, and 5D, lanes 4 and 5).
In a previous report, JEV NS5 was shown to bind to the
83-nt stem-loop structure formed with the 3'-terminal
region of JEV genome, as demonstrated by UV-cross-link-
ing experiments using JEV-infected cell extracts [23]. We
also were able to confirm the direct interaction between
the purified NS5 and this cis-acting RNA element by elec-
trophoretic mobility shift assay (data not shown). These
results prompted us to test whether JEV NS5 can utilize
this 83-nt RNA as a template for minus-strand RNA syn-
thesis. As expected by its binding ability to the 83-nt RNA,
NS5 could direct RNA synthesis to yield a major RdRp
product that migrated similarly to the template RNA on a
denaturing polyacrylamide gel (20 × 20 cm) (Fig. 5D).
There was no generation of RNA products bigger than the
template, suggesting that NS5 does not have a detectable
level of TNTase activity that would add nucleotide(s) to
the 3'-end of the template, under the standard RdRp reac-
tion conditions we used. Furthermore, we observed no
dimer-size products, suggesting there was no "copy-back"
initiation mediated by intramolecular priming. Next, we
analyzed whether the products synthesized from this min-
imal RNA template are in the single- or double-stranded
form. We treated the RNA products with nuclease S1
under low or high salt conditions and found that they
were sensitive to nuclease S1 digestion regardless of heat
denaturation prior to the nuclease treatment under the
low salt (50 mM NaCl) condition (Fig. 6, lanes 2 and 5).
In contrast, the products were almost resistant to nuclease
S1 under the high salt (500 mM NaCl) condition (lanes 3
and 6), which is a favorable condition for forming a stable
RNA duplex. This result suggested that the most of RdRp
products directed by the 83-nt RNA template might form
a stable RNA duplex with the template or with the product
itself.
De novo internal initiation of RNA synthesis from the 83-
nt RNA template
To fine map the initiation site of RNA synthesis from the
83-nt RNA template, we resolved the RdRp-reaction prod-
uct on a denaturing polyacrylamide sequencing gel (20 ×
45 cm) and determined the exact size of the RNA product
by running in parallel with RNA size markers. The result
showed that the size of the major product from the 83-nt
RNA template is 81-nt long, shorter than the template
RNA (Figs. 7A and 7B, lane 3), indicating that JEV NS5 ini-
tiated RNA synthesis from the internal nucleotide U81 of
the template, as depicted in Fig. 7C. We attempted, with-
out success, to detect 5'-end labeled internally initiated
products from the RdRp assays performed in the presence
of [γ-32P] ATP and all four cold ribonucleotides (data not
shown). The limited amount of [γ-32P] ATP (0.33 μM) and
cold ATP (1 or 5 μM), which might be lower than the Km
value for ATP required for efficient initiation of RNA syn-
thesis, and less sensitive 5'-end labeling of the internally
initiated RNA products with single radiolabeled ribonu-
cleotide than the internal labeling at multiple sites with
[α-32P] UTP, may explain this failure. Therefore, instead of
using the [γ-32P]-ATP incorporation assay, we performed
RdRp assays with insertion and deletion mutants of the
83-nt RNA, namely 83(Δ1) (deletion of U residue from
the 3'-end of the 83-nt RNA), 83(+U) (addition of extra U
residue to the 3'-end of the 83-nt RNA), and 83(+ST2)
(addition of single base pair at the lower stem-region of
the 83-nt RNA) (Fig. 8A) to confirm the internal de novo
initiation of RNA synthesis. Strikingly, the first two deriv-
atives, 83(Δ1) and 83(+U), still directed the synthesis of
an 81-nt RNA product co-migrating with the RNA product
synthesized from the wild-type template (Fig. 8B, com-
pare lanes 2 and 4 with lane 3). Deletion of one nucle-
otide from the 3'-terminal end of the template or addition
of one nucleotide to the 3'-end did not alter the size of the
reaction product, indicating that RNA synthesis initiation
did not start from the 3'-end of the template. In contrast,
the 83(+ST2) RNA (total 85-nt in length) with an addi-
tional base pair at the lower part of the stem structure
yielded an 83-nt product (lane 5). These results clearly
indicated that the NS5 initiates RNA synthesis from the
U81 of the template.
TNTase activity of JEV NS5 protein
Recent studies have shown that recombinant HCV NS5B
and BVDV NS5B RdRps expressed in E. coli have an intrin-
sic TNTase activity; TNTase activity was not an activity of
any cellular enzyme co-purified with the recombinant
RdRps but an inherent function of the RdRps [24]. We set
out similar TNTase assay conditions as depicted in Fig. 9.
Similar to the previous results shown with HCV and
BVDV RdRps, labeled products were detected in the
TNTase activity assays performed in the presence of [α-
32P] UTP and cold UTP (10 μM) or in the presence of [α-
32P] UTP as a sole ribonucleotide substrate. Under these
conditions, recombinant JEV NS5 synthesized template
size and bigger-than-the template products but not the
internally initiated 81-nt RNA product (Fig. 9, lanes 3 and
4). Consistently, in the standard RdRp reaction condition,
JEV NS5 produced the 81-nt internally initiated RNA
product (lane 2). Upon longer exposure to detect the
TNTase activity in the presence cold UTP, we observed an
additional minor product (<5 nt smaller than the 81-nt
RNA product), which we were not able to detect underBMC Molecular Biology 2007, 8:59 http://www.biomedcentral.com/1471-2199/8/59
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routine RdRp product analysis conditions. These results
suggest that JEV NS5 might possess a TNTase activity,
depending on reaction conditions.
Discussion
In this study, we established an in vitro JEV RdRp assay sys-
tem with a functional full-length JEV NS5 protein and
characterized the mechanism of initiation of RNA synthe-
sis. Results from this study showed that the recombinant
JEV NS5 exhibits both RdRp and TNTase activities. The
enzyme was capable of synthesizing RNA by a primer-
dependent manner with a homopolymeric RNA template
poly(A) and by de novo initiation with the RNA templates
derived from JEV genome. Several reports showed that the
TNTase activity is a common intrinsic property of many
RdRps of Flaviviridae. The recombinant RdRps of HCV and
BVDV have been shown to possess a TNTase activity under
certain reaction conditions [24,25]. CSFV NS5B protein
also was shown to possess TNTase activity, which added a
single nucleotide to the 3' end of the 3'-UTR RNA tem-
plate [26]. The JEV NS5 exhibited a weak but detectable
level of intrinsic TNTase activity only when substrate ribo-
nucleotides were limited (Fig. 9, lanes 3 and 4). Because
the TNTase activity was detected only when limiting
amount of cold UTP was added to the reaction mixture, its
in vivo function, if any, remains unclear.
The JEV NS5 has a strong preference for Mn2+ over Mg2+
ion for RNA synthesis (Figs. 3 and 4). Considering that the
intracellular concentration of Mn2+ is much lower than
Mg2+ [11], the stringent Mn2+-dependent RdRp activity of
JEV NS5 may not allow efficient JEV replication in vivo.
Alternatively, this Mn2+-dependent RdRp activity might be
simply an artifact of the unnatural in vitro conditions. It is
also possible that this might be due to conformational dif-
ference of the recombinant JEV NS5 from the one in the
virus-infected cells, in which JEV NS5 was likely to be
membrane associated or to form a complex with other
viral and/or cellular proteins. Nevertheless, similar strin-
gent Mn2+-denpedent RNA synthesis using the homopol-
ymeric RNA template poly(C) has been demonstrated
with recombinant RdRps DEN and WNV [27]. Further-
more, when a DEN minigenome consisting of the 5'-end
RNA (224 nt) and the 3'-end RNA (492 nt) of the viral
genome was used as a template, the DEN RdRp activity
was supported either by Mg2+ or Mn2+, with the latter cat-
ion being a better cofactor. Our result is however contra-
dictory to that obtained previously by in vitro RdRp assay
De novo initiation of RNA synthesis from the plus- and minus-strand 3'-UTR of the JEV genome Figure 5
De novo initiation of RNA synthesis from the plus- and minus-strand 3'-UTR of the JEV genome. RdRp assays 
were performed with the purified wild-type NS5 (WT) and mutant NS5D668A (Mt) in the presence (+) or absence (-) of JEV 
3'(+)UTR RNA (A and C), 3' (-)UTR RNA (B and C), and the 83-nt RNA (D) template. RdRp products were analyzed as in Fig-
ure 4 by autoradiography. Arrowheads indicate the template positions visualized by ethidium-bromide staining of the gels.BMC Molecular Biology 2007, 8:59 http://www.biomedcentral.com/1471-2199/8/59
Page 7 of 12
(page number not for citation purposes)
using the JEV replication complex (RC) isolated from
infected cells [28]. The RC displayed a strict dependence
on Mg2+ with absolutely no RdRp products being synthe-
sized from the endogenous viral RNAs associated with the
RC in the absence of Mg2+. The requirement of Mg2+ for
RNA synthesis by JEV RC might be due, in part, to its role
as a cofactor for other viral and/or cellular proteins asso-
ciated with the viral RNA polymerase.
During the course of flavivirus replication, minus-strand
RNA is synthesized from the plus-strand genomic RNA.
This intermediate form of RNA serves as a template for the
synthesis of plus-strand genomic RNA that is synthesized
at 10- to 100-fold higher levels than the minus-strand
RNA [4]. Results from our in vitro RdRp assays using the
3'(+)UTR and 3'(-)UTR templates also supported the
notion that a greater amount of plus-strand RNA than
minus-strand RNA is synthesized in JEV- and DEN-
infected cells [28,29]. The ratio of plus-to-minus strand
Nuclease S1 treatment of the RNA products synthesized  from the 83-nt RNA template Figure 6
Nuclease S1 treatment of the RNA products synthe-
sized from the 83-nt RNA template. Heat-denatured 
(+Δ) or untreated (-Δ) RdRp products synthesized from the 
83-nt RNA, which represents the 3'-terminal region of JEV 
genome, were left untreated (-) or digested with nuclease S1 
(S1), and resolved on a denaturing polyacrylamide gel. Nucle-
ase S1 treatments were performed in 50 mM NaCl (L; low 
salt) or 500 mM NaCl (H; high salt). Arrowhead indicates the 
position of the 83-nt RNA template.
Mapping of the RNA synthesis initiation site on the 83-nt  RNA template Figure 7
Mapping of the RNA synthesis initiation site on the 
83-nt RNA template. The RdRp assay was performed with 
the 83-nt RNA template. (A) An autoradiogram showing the 
major RNA product synthesized by JEV NS5 using the 83-nt 
RNA template. Products were resolved on a 5% polyacryla-
mide sequencing gel (20 × 40 cm) containing 8 M urea. The 
RNA size markers, 5'-end labeled RNA template (End), and a 
set of labeled RNA fragments generated by alkaline hydroly-
sis of the 5'-end labeled RNA template (End/OH), were 
resolved on the same gel. Arrowhead indicates the internally 
initiated 81-nt RNA product. (B) The close-up autoradio-
gram of the same gel shown in (A). (C) Secondary structure 
of the 83-nt RNA template predicted by the Mfold program. 
Bent arrow denotes the predicted RNA synthesis initiation 
site.BMC Molecular Biology 2007, 8:59 http://www.biomedcentral.com/1471-2199/8/59
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RNA in the cells infected with these viruses was approxi-
mately 10:1. As shown in Fig. 5C, we demonstrated that
the 3'(-)UTR served as a better template than the 3'(+)UTR
for JEV NS5. This in vitro result also agreed with the result
showing that the HCV NS5B RNA polymerase produces
RdRp products more efficiently using the 3'(-)UTR than
the 3'(+)UTR of the plus-strand viral RNA [30]. Such pref-
erence for plus-strand 3'-UTR over minus-strand 3'-UTR
for RNA synthesis initiation might be correlated with the
binding activity of RdRps to these cis-acting RNA ele-
ments. Indeed, a recent report showed that CSFV NS5B
protein, a viral RdRp, recognizes the 3'(-)UTR more effi-
ciently than the 3' (+)UTR [26]. Regarding the mechanism
of initiation of RNA synthesis, JEV NS5 appears to be able
to initiate RNA synthesis either de novo or by intramolecu-
lar priming in vitro using the viral genome-derived RNA
templates tested in this work. From the 3'(+)UTR, JEVNS5
produced template size RNA as a major RdRp product,
whereas bigger-than-template products were synthesized
from the 3'(-)UTR RNA template (Fig. 5C). The nature of
this bigger-than-template product is not clear at the
present time, although it might be generated by extension
of the 3'-end of the template by a snap-back priming
mechanism or by extension of the newly synthesized nas-
cent RNA products. The long single-stranded region at the
3'-end of the predicted secondary structure of the 3'(-)UTR
might allow intramolecular priming.
Effect of nucleotide addition and deletion at the lower part of  the stem-loop structure of the 83-nt RNA template on RNA  synthesis initiation Figure 8
Effect of nucleotide addition and deletion at the 
lower part of the stem-loop structure of the 83-nt 
RNA template on RNA synthesis initiation. (A) 
Sequences and secondary structures of wild-type 83-nt RNA 
and its derivatives. Names and ρ G are shown below the 
structures predicted by the Mfold program. Partial structures 
representing the lower stem-region are shown. The deleted 
and added nucleotides are indicated by ρ and boxed, respec-
tively. (B) RNA synthesis directed by the wild-type 83-nt 
RNA and its derivatives. RdRp assays were performed with 
the RNA templates indicated above the autoradiogram, and 
products were resolved a 5% polyacrylamide sequencing gel 
(20 × 40 cm) containing 8 M urea. Arrowhead indicates the 
81-nt internally initiated RNA product. Representative data 
from three independent experiments are shown.
TNTase activity of JEV NS5 Figure 9
TNTase activity of JEV NS5. The 83-nt RNA was used as 
a template for RdRp and TNTase activity assays. For TNTase 
activity assays, reactions were performed in the presence of 
cold UTP and [α-32P] UTP (lane 3), or in the presence of sin-
gle [α-32P] UTP (lane 4). An RNA product from the standard 
RdRp reaction mixture is shown as a control (lane 2). Lane 1, 
5'-end labeled 83-nt RNA size marker.BMC Molecular Biology 2007, 8:59 http://www.biomedcentral.com/1471-2199/8/59
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Both nucleotide sequence and structure of 3'-UTR of plus-
strand RNA viruses contain a cis-acting signal essential for
the initiation of viral RNA replication. Although the size
and sequence of the 3'-UTR vary among different flavivi-
ruses, its secondary structure comprising stable stem-
loops is predicted to be highly conserved. The last 80 to 90
nts at the 3'-end of various flavivirus genomes have been
predicted to form stable stem-loop structures [31-33]. The
last 83-nts of the 3'-UTR of JEV are predicted to form a sta-
ble stem-loop structure (Fig. 7C), which is similar to that
formed with the 3'-end of the KUN genome [34]. The abil-
ity of JEV NS5 to use the 83-nt RNA template as a minimal
template allowed us to explore its role in RNA synthesis.
Our results revealed that JEV NS5 initiates RNA synthesis
from an internal nucleotide U81, the third nucleotide from
the 3'-end of the template (Fig. 7). We also observed that,
although it is a very minor one, wild-type 83-nt RNA (83
WT), 83(Δ1), and 83(+U) generated an RNA product of
83-nt (Fig. 8). Because de novo initiated products from the
3'-end of these templates would generate 82, 83, and 84-
nt product from 83(Δ1), 83 WT, and 83(+U), respectively,
this product appears to be the 3'-end extended nascent
RNA. Internal initiation of RNA synthesis was observed
similarly with other Flaviviridae RdRps. For example, the
penultimate cytidine at the 3'-end of KUN plus- and
minus-strand RNA was shown to be essential for KUN
RNA replication [34]. In addition, Oh et al. [17] and Kim
et al. [35] showed that RNA synthesis initiates from an
internal region of the 98-nt X-RNA template at the 3'-end
of HCV genome, which is similar in terms of the RNA syn-
thesis initiation mechanism to the result shown with JEV
NS5 in this study. Because initiation of RNA synthesis
from an internal nucleotide during viral RNA replication
will result in loss of 3'-end genetic information, cellular
and/or viral factors may play a role in the initiation of
RNA synthesis from the 3'-end of genome. Previously,
Chen et al. (8) showed that both JEV NS3 helicase and
NS5 bind to the 3'-UTR of JEV genomic RNA. Moreover,
the 36-kDa Mov34 protein was known to bind the 83-
nucleotide 3' stem-loop structure recognized by the NS5
protein [23,36]. Those known viral and cellular proteins
interacting with the 3'-end minimal cis-acting elements as
well as other unknown factors might allow for JEV NS5
protein to initiate RNA synthesis from the 3'-end. The
recombinant JEV NS5 protein will permit evaluating the
effect of such trans factors on initiation of RNA synthesis.
Previous studies proposed that the 5' and 3' ends of the
flavivirus RNA genome are able to interact directly
between the cyclization sequence within the 3'-UTR and
its complementary sequence in the capsid coding region
following the 5'-UTR of the viral genome [37]. The cross-
talk between these conserved cis-acting RNA elements of
various flaviviruses was shown to be required for viral rep-
lication [38-40]. In vitro RdRp assays using DEN-infected
cell lysates and recombinant viral RdRp from WNV
showed that minus-strand RNA synthesis requires the
interaction between the two terminal regions on the plus-
strand viral RNA template through a cyclization motif,
[18,21,41]. These previous results proposed that RNA syn-
thesis from the 3'-UTR of plus-strand RNA requires the 5'-
terminal region of the viral genome supplied in cis or trans
so that cyclization of the 5'- and 3'-terminal regions forms
a pan-handle-like structure. In contrast to in vitro RdRp
assay results obtained with the above described flavivirus
RdRps, our results demonstrated that JEV NS5 protein is
capable of using the JEV 3'(+)UTR and the 83-nt RNA as
templates (Fig. 5). RNA synthesis from these templates
did not require the 5'-terminal cyclization motif in cis or
trans. This result suggests that the sequence and/or struc-
ture of the 3'(+)UTR and the 83-nt RNA is sufficient for
the NS5 to recognize the template and to initiate RNA syn-
thesis, and indicates that cyclization of the JEV genome is
not required for RNA synthesis in vitro. Thus, it is tempting
to speculate that cyclization of the JEV RNA genome in
vivo, if any, via direct RNA-RNA interaction or indirect
interaction through other cellular and/or viral proteins, is
involved in viral genome translation.
Conclusion
We established an in vitro JEV RdRp assay system with an
enzymatically active recombinant JEV NS5 protein. This
recombinant JEV alone was able to recognize the cis-acting
elements on both plus- and minus-strand 3'-ends. Like
some of other flavivirus RdRps, it carries both RdRp and
intrinsic TNTase activities. Its internal do novo RNA initia-
tion from the 83-nt RNA template suggests that JEV RNA
replicase complex might require viral and/or cellular pro-
teins to direct RNA synthesis initiation form the 3'-end in
vivo. The recombinant JEV NS5 protein will facilitate the
analysis of the roles of such factors in initiation of RNA
synthesis. The functional NS5 protein will also be useful
for the development of target-specific inhibitors of JEV
replication.
Methods
Cells and virus
Baby hamster kidney cells (BHK-21) were grown at 37°C
in minimum essential medium (MEM, Invitrogen Life
Technologies) supplemented with 5% fetal bovine serum
(FBS, Invitrogen) and 1% penicillin/streptomycin sulfate
(Invitrogen). The Nakayama strain of JEV, which was pre-
pared from virus-infected mouse brain, was provided by
the Department of Viral Disease, Korea National Institute
of Health and used in our study. BHK-21 cells were
infected with JEV at an multiplicity of infection of five as
described previously [42].BMC Molecular Biology 2007, 8:59 http://www.biomedcentral.com/1471-2199/8/59
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Construction of the recombinant JEV NS5 expression 
vector
To obtain a cDNA fragment encoding JEV NS5, viral
genomic RNA from culture supernatants of JEV-infected
BHK-21 cells was extracted with Trizol LS reagent (Invitro-
gen Life Technologies). After phenol/chloroform extrac-
tion, purified RNA was precipitated with isopropanol,
washed once with 70% ethanol, and dissolved in RNase-
free water. The RNA was reverse transcribed using Super-
script II reverse transcriptase (Gibco-BRL) and the reverse
primer 5'-GGGGTACCGATGACCCTGTCTTCCTG-3' as
instructed by the manufacturer. The NS5 coding sequence
was amplified by PCR, using Vent DNA polymerase (New
England Biolabs) along with the forward primer (5'-
CTAGCTAGCGGAAGGCCCGGGGGCAGG-3') and the
reverse primer. The PCR product was digested with NheI
and KpnI and ligated into a similarly digested pTrcHisB
(Invitrogen) vector to make the plasmid pTrcHisB-
JEVNS5. The JEV NS5 mutant NS5D668A with a substitu-
tion of the first Asp with Ala in the GDD motif was gener-
ated by site-directed mutagenesis with two sequential
rounds of PCR using oligonucleotides containing the tar-
get mutation as described previously [12]. The presence of
the desired mutation was verified by DNA sequencing.
Expression and purification of recombinant JEV NS5 
protein from E. coli
JEV NS5 protein was expressed in E. coli TOP10 cells (Inv-
itrogen) transformed with pTrcHisB-JEVNS5. The trans-
formed cells were grown in LB medium containing 100 μg
of ampicillin per ml to an optical density at 600 nm of
0.6–0.8 at 37°C, and protein expression was induced at
18°C for 12 h by addition of 1 mM isopropyl-β-D-thioga-
lactopyranoside (IPTG). The NS5 protein was purified by
metal affinity chromatography using Ni-nitrilotriacetic
acid (NTA)-agarose (Qiagen) resin as described previously
[12]. The bound JEV NS5 proteins were step-eluted with
the binding buffer containing 50 to 500 mM imidazole.
JEV NS5-containing fractions were collected, dialyzed
against a gel filtration column buffer (50 mM Tris-HCl
[pH 7.8], 150 mM NaCl, 1 mM DTT, 0.5 mM EDTA), and
then applied to a Sephacryl S-200HR column (Amersham
Biosciences) at a flow rate of 0.5 ml/min. JEV NS5-con-
taining fractions were collected and dialyzed against
buffer A (50 mM Tris-HCl [pH 8.0], 50 mM NaCl, 1 mM
DTT, 10% glycerol), and purified further by applying to an
SP-Sepharose column (Amersham Biosciences). Adsorbed
proteins were eluted with a 5 ml linear gradient of NaCl
from 0.1 to 1 M in buffer A. Small aliquots of the NS5-
containing fractions were stored at -80°C after dialyzing
against buffer A. Protein concentrations were determined
using a Bio-Rad protein assay kit with bovine serum albu-
min as a standard.
RNA template preparation
The DNA templates for 3'(+)UTR (representing the 3'-UTR
of JEV genome), 3'(-)UTR RNA (representing the region
complementary to the 5'-UTR of JEV genome), the 83-nt
RNA template (representing the 83-nt RNA from the 3'-
end of JEV genome) were obtained by PCR with Vent DNA
polymerase and the specific primers for 3'(+)UTR RNA
(5'-TAATACGACTCACTATAGCTAGTGTGATTTAAAGTA-
3' and 5'-AGATCCTGTGTTCTTCC-3'), 3'(-)UTR RNA (5'-
AGAAGTTTATCTGTGTG-3' and 5'-TAATACGACTCAC-
TATAGGTTATCTTCCGTTCTAA-3'), and the 83-nt RNA
(5'-TAATACGACTCACTATAGATCTTCTGCTCTATCTC-3'
and 5'-AGATCCTGTGTTCTTCC-3'). The T7 RNA
polymerase promoter sequence is underlined, and the
sequence complementary to the JEV genome sequence is
shown in boldface and italic. pBACSP6/JVFL/XbaI [43],
which was kindly provided by Dr. Y. M. Lee at Chungbuk
National University, Cheongju, Korea, was used as a tem-
plate for PCR. Various DNA templates for derivatives of
the 83-nt RNA were generated by PCR using a set of spe-
cific primers. The PCR-amplified DNA products were gel
purified and used for in vitro transcription using T7 RNA
polymerase as described previously [17]. RNA concentra-
tions were estimated by measuring the absorbance at 260
nm.
Enzymatic assays and analysis of products
RdRp assays were performed with 500 ng of purified JEV
NS5 RdRp in a total volume of 25 μl containing 50 mM
Tris-HCl (pH 8.0), 50 mM NaCl, 25 mM potassium gluta-
mate, 1 mM MgCl2, 2.5 mM MnCl2, 1 mM DTT, 10% glyc-
erol, 20 units of RNase inhibitor (Promega), cold
ribonucleotide mixture (0.5 mM each ATP, CTP, and GTP,
and 5 μM UTP), and 10 μCi of [α-32P] UTP (3,000 Ci/
mmol; Amersham Biosciences). The reaction mixture was
incubated with 200 ng of RNA template for 2 hr at 30°C.
For RdRp reaction with poly(A) template, 1 μg of RNA was
added to the reaction mixture as described above, except
that 10 μM UTP was included in the reaction with 2 μCi
of [α-32P] UTP. The RdRp reactions were performed in the
absence or presence of 10 pmol of oligonucleotide (U)20.
For the TNTase assay, 10 μCi of [α-32P] UTP mixed with or
without 10 μM of cold UTP was used as a single ribonu-
cleotide in the RdRp reaction mixture with the 83-nt RNA
as a template. [γ-32P]-ATP incorporation assay was per-
formed as described above for the standard RdRp assay,
except that the reaction mixture contained cold ribonucle-
otide mixture (0.5 μM each CTP, GTP, and UTP, and 1 μM
or 5 μM ATP) and 0.33 μM [γ-32P]-ATP (6,000 Ci/mmol,
10 mCi/ml; Amersham Biosciences).
RdRp reaction products were precipitated and resus-
pended in a denaturing loading buffer as described previ-
ously [12]. After heat denaturation and quick chilling on
ice, the RNA products were resolved on 8 M urea-5% poly-BMC Molecular Biology 2007, 8:59 http://www.biomedcentral.com/1471-2199/8/59
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acrylamide gels (20 × 20 cm), unless otherwise specified.
For size mapping, RNA products were separated in 8 M
urea-6% denaturing polyacrylamide gels (20 × 45 cm).
The gels were stained with ethidium bromide, photo-
graphed to locate the template positions, and then dried.
The dried gels were exposed to X-ray film (BioMax XAR,
Kodak) for autoradiography. The amounts of 32P-UMP
incorporated into the products were measured in a LS-
6500 multi-purpose scintillation counter (Beckman).
Nuclease S1 treatment
RdRp products were digested with 4 units of nuclease S1
per ml (Promega) at 37°C for 30 min in nuclease S1
digestion buffer (30 mM NaOAc [pH 4.6], 1 mM ZnSO4,
5% glycerol) containing either a low (50 mM) or high
(500 mM) concentration of NaCl.
Preparation of RNA size markers
For 5'-end 32P-labeling of the 83-nt RNA, in vitro tran-
scripts were dephosphorylated with calf intestine alkaline
phosphatase (Takara Bio Inc.), and then phosphorylated
with T4 polynucleotide kinase (New England Biolabs) in
a final reaction volume of 50 μl containing 50 μCi [γ-32P]
ATP and 0.1 mM cold ATP. After incubation at 37°C for
30 min, free nucleotides were removed using a Sephadex
G-25 spin column, and the labeled RNA was purified from
the denaturing polyacrylamide gel as described previously
[17]. The 32P-labeled 83-nt RNA was partially digested by
incubation in Na2CO3/NaHCO3 buffer (pH 10) for 10
min at 90°C.
Prediction of RNA secondary structure
RNA secondary structures were analyzed by the Mfold
program [44]. The structure drawings were edited and
annotated using the RnaVis 2 program [45].
SDS-PAGE, Western blot analysis, and MALDI-TOF 
analysis
For Western blot analysis, protein samples were resolved
by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE), and then transferred to nitrocellu-
lose membranes (Amersham Biosciences). The samples
were blocked using 5% skim milk in TBST (20 mM Tris-
HCl [pH 7.4], 150 mM NaCl, 0.1% Tween 20), then
reacted with an anti-His antibody (Qiagen) at a 1:1,000
dilution, followed by incubation of goat anti-mouse lgG
conjugated with peroxidase (Sigma-Aldrich). The immu-
noblots were washed and then immunoreactive protein
bands were visualized using enhanced chemilumines-
cence (ECL, Amersham Biosciences). Silver staining of
gels and matrix-assisted laser desorption/ionization-time
of flight mass spectrometry (MALDI-TOF MS) analysis
were performed as described previously [46].
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